Source:http://linkedlifedata.com/resource/pubmed/id/10022459
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1999-2-25
|
pubmed:abstractText |
Patients with the nephrotic syndrome (NS) exhibit abnormal renal sodium retention which cannot completely explained by a secondary hyperaldosteronism due to reduced renal perfusion. As an alternative mechanism to explain this phenomenon we postulate a cortisol-mediated mineralocorticoid effect as a consequence of a reduced activity of 11beta-hydroxysteroid dehydrogenase (11beta-HSD). A down-regulation of 11beta-HSD, i.e. of the shuttle of active to inactive glucocorticosteroids, has been shown to cause mineralocorticoid effects. Therefore we investigated the activity of 11beta-HSD by measuring the urinary ratio of (tetrahydrocortisol + 5alpha-tetrahydrocortisol)/tetrahydrocortisone [(THF+5alpha-THF)/THE] by gas-chromatography in 29 NS patients with biopsy-proven glomerulonephritis and 29 healthy control subjects. The ratio of (THF+5alpha-THF)/THE was higher in NS patients (median 1.49, range 0.45-4.07) than in the control subjects (0.98, 0.60-1.36; p<0.01). This ratio was increased as a consequence of a decreased urinary excretion rate of the cortisone metabolite, THE. The present data indicate that a reduced activity of 11beta-HSD is a new mechanism contributing to the exaggerated sodium retention in patients with the NS.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/11-beta-Hydroxysteroid...,
http://linkedlifedata.com/resource/pubmed/chemical/Hydroxysteroid Dehydrogenases,
http://linkedlifedata.com/resource/pubmed/chemical/Tetrahydrocortisol,
http://linkedlifedata.com/resource/pubmed/chemical/Tetrahydrocortisone
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0021-972X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
84
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
811-4
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10022459-11-beta-Hydroxysteroid Dehydrogenases,
pubmed-meshheading:10022459-Adult,
pubmed-meshheading:10022459-Aged,
pubmed-meshheading:10022459-Aged, 80 and over,
pubmed-meshheading:10022459-Female,
pubmed-meshheading:10022459-Humans,
pubmed-meshheading:10022459-Hydroxysteroid Dehydrogenases,
pubmed-meshheading:10022459-Male,
pubmed-meshheading:10022459-Middle Aged,
pubmed-meshheading:10022459-Nephrotic Syndrome,
pubmed-meshheading:10022459-Tetrahydrocortisol,
pubmed-meshheading:10022459-Tetrahydrocortisone
|
pubmed:year |
1999
|
pubmed:articleTitle |
Reduced 11beta-hydroxysteroid dehydrogenase activity in patients with the nephrotic syndrome.
|
pubmed:affiliation |
Department of Medicine, University of Berne, Inselspital, Switzerland.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|